Skip to main content

Articles

A study evaluating different ways of helping men consider prostate-specific antigen (PSA) screening shows that the patient’s decision-making process was influenced by the format in which information was offered.
Read More ›

For those patients with multiple myeloma whose disease has progressed after being treated with other cancer drugs, the FDA has recently approved a new drug, Pomalyst (pomalidomide).
Read More ›

Researchers recently studied the effects of intimate partner violence and childhood sexual abuse on a woman’s levels of depression, perceived stress, and cancer-related well-being.
Read More ›

According to a new study, the underlying medical conditions affecting young adults who undergo CT exams are a significantly greater health risk than that of radiation-induced cancer from CT.
Read More ›

Researchers compared outcomes among prostate cancer patients treated with surgery and those treated with radiotherapy and discovered that differences in urinary, bowel, and sexual function exist after short-term follow-up.
Read More ›

Compared with annual breast cancer screenings, mammograms every 2 years were just as beneficial for older women.
Read More ›

The FDA has approved the first generic version of the cancer drug, Doxil.
Read More ›

Women smokers today smoke more like men than women in previous generations.
Read More ›

Recent research points to an association between vegetable consumption and a lower risk of estrogen receptor–negative breast cancer.
Read More ›

Over the past 10 years, women have increasingly been choosing to treat their breast cancer with mastectomy instead of lumpectomy combined with radiation, even for very small cancers.
Read More ›

Page 177 of 289